Home Categories MonoMethylauristatinE
A1002850

MonoMethylauristatinE , 97% , 474645-27-7

CAS NO.:474645-27-7

Empirical Formula: C39H67N5O7

Molecular Weight: 717.98

MDL number: MFCD28400134

Pack Size Price Stock Quantity
5mg RMB223.20 In Stock
10mg RMB399.20 In Stock
25mg RMB639.20 In Stock
50mg RMB799.20 In Stock
100mg RMB1279.20 In Stock
250mg RMB2399.20 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: >90°C (dec.)
Boiling point: 873.5±65.0 °C(Predicted)
Density  1.088±0.06 g/cm3(Predicted)
storage temp.  -20°C Freezer
solubility  DMSO (Slightly), Methanol (Slightly, Sonicated)
pka 13.66±0.20(Predicted)
form  Solid
color  White to Off-White
InChIKey RJACXSRFJLSJEZ-UIJRFTGLSA-N
SMILES C(NC(=O)[C@H](C(C)C)NC)(=O)[C@H](C(C)C)N([C@@H]([C@@H](C)CC)[C@H](OC)CC(N1CCC[C@H]1[C@H](OC)[C@@H](C)C(N[C@H](C)[C@@H](O)C1=CC=CC=C1)=O)=O)C

Description and Uses

MMAE is a synthetic antineoplastic agent. Because of its toxicity, it cannot be used as a drug itself; instead, it is linked to a monoclonal antibody (MAB) which directs it to the cancer cells. Monomethyl auristatin E or MMAE is 100-1000 times more potent than doxorubicin. It is a very potent antimitotic agent that inhibits cell division by blocking the polymerization of tubulin.

Dolastatin 10 is a natural antimitotic and antineoplastic agent that binds to tubulin and inhibits tubulin polymerization. Monomethyl Auristatin E (MMAE) is a synthetic analog of dolastatin 10 that similarly inhibits tubulin polymerization and exhibits potent cytotoxicity. It is commonly conjugated with monoclonal antibodies directed at antigens specific to cancer cells for tumor-directed cytotoxicity. MMAE is typically coupled to the antibody via a protease-cleavable linker, allowing separation of the drug from the antibody following intracellular localization.[Cayman Chemical]

Safety

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H302-H315-H319-H335
Precautionary statements  P261-P305+P351+P338

RELATED PRODUCTS